Recent YSCC Discoveries
Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab—recently approved for pediatric patients with Stage III type 1 diabetes—delays the progression of the disease.
- June 24, 2026
A new Yale study reveals that your blood vessels operate as a coordinated signaling network—and uncovers the consequences of disrupting that network.
- June 18, 2026
Two faculty members were honored for their mentorship of physician-scientists at the 2026 Janeway Society retreat.
- June 16, 2026
Introducing Yale School of Medicine Department of Dermatology's Spring 2026 Annual Report! This inaugural edition features the latest updates in patient care, research, and education throughout the department over the last year.
- June 16, 2026
Earlier this month, Yale Cancer Center and the Center for Thoracic Cancers, hosted a Lung Cancer Scientific Symposium celebrating the remarkable advances in lung cancer research over the last decade and Dr. Roy Herbst’s 15 years of leadership at Yale.
- June 16, 2026Source: U.S. News & World Report (with Hugh Taylor, MD)
PMOS is a chronic condition with life-long symptoms that can be serious, in both a physical and emotional sense. There is no cure for PMOS, nor is the cause of the condition clear, but treatments do exist to help individuals manage their PMOS symptoms and improve both their health and quality of life.
- June 14, 2026Source: WTNH
Dozens of families came together Sunday (June 14) for an annual event in Bridgeport to reconnect with their care teams from Yale New Haven Children’s Hospital Fetal Care Center. Yale faculty leaders spoke with WTNH.
- June 12, 2026
Scientists expected that wiping out most of the skin's fibroblast population would shut down stem cell growth. Instead, the skin barely flinched.
- June 11, 2026
In a new study, Yale researchers examined associations between industry payments and prescribing patterns among physicians treating pulmonary arterial hypertension, a rare but serious condition characterized by progressive damage to the arteries that supply blood to the lungs.
- June 11, 2026
A massive scientific initiative to decode how aging reshapes the human body reached a major milestone this month. The National Institutes of Health (NIH) Cellular Senescence Network (SenNet) published its first wave of discoveries, highlighted by a cover commentary in the journal Cell led by Rong Fan, PhD, Harold Hodgkinson Professor of Biomedical Engineering at Yale School of Engineering and Applied Science (SEAS) and of Pathology at Yale School of Medicine (YSM), alongside researchers from nine other institutions.